How Healthcare and Life Sciences Companies Can Benefit from Blockchain

How Healthcare and Life Sciences Companies Can Benefit from Blockchain

“The reason why it is so difficult for existing firms to capitalize on disruptive innovations is that their processes and their business model that make them good at the existing business actually make them bad at competing for the disruption.” – Clayton Christensen Most agree that Distributed Ledger – Blockchain (DLBC) technology has the ability to transform how data is managed and...

Read More
Top 6 Ways to Combat Change Fatigue

Top 6 Ways to Combat Change Fatigue

When I read Bill’s blog “Where’s the Snooze Button on Change?” I was inspired to write my own perspective on managing change. And then I hit my own snooze button a few times in the last few months due to some competing priorities. Change fatigue is real – and something I observe often at clients.…

Read More
Are Apple’s ResearchKit and CareKit ready for the Big Leagues?

Are Apple’s ResearchKit and CareKit ready for the Big Leagues?

Apple created a new series of healthcare application development frameworks in early 2016. The new open-source frameworks, CareKit and ResearchKit, provide a standard platform that enables developers to build medically-focused research and care apps with built-in features related to end-to-end data encryption, privacy, and standardized data sharing. CareKit allows users to track their...

Read More
More Data, More Problems… Leveraging the Azure Import/Export Tool

More Data, More Problems… Leveraging the Azure Import/Export Tool

In today’s market businesses are likely familiar with the enterprise services provided in Azure and have already started planning a cloud transition.  As Azure expands its core offering and more business transition to a cloud platform, the question becomes, “how does an organization move large amounts of data to the cloud, specifically to Azure?”  Introducing the Microsoft Azure Import/Export...

Read More
How to Capture Market Share Through Data-Driven Drug Discovery

How to Capture Market Share Through Data-Driven Drug Discovery

For years pharmaceutical companies have taken existing drugs and repurposed or repositioned them to create new drugs. These new drugs are often geared towards neglected therapeutic areas. Drug repurposing has always been a solid “go to” strategy and a proven method for mitigating the financial risk of drug discovery and a means of addressing softening market share.…

Read More
M&A in Pharmaceuticals and Medical Devices: How to Stop Value Leakage

M&A in Pharmaceuticals and Medical Devices: How to Stop Value Leakage

Most pharmaceutical executives would argue that M&A is critical to drive shareholder value. Transactions can help realize new discovery capabilities, procure new compounds to strengthen stagnant drug development pipelines, or save money, all of which can create a competitive advantage in the market.  The numbers speak for themselves. In 2015, healthcare M&A increased 66%, reaching a...

Read More
In the “Buy vs. Build” world of Pharma, Does Lab Productivity Still Matter?

In the “Buy vs. Build” world of Pharma, Does Lab Productivity Still Matter?

The cost of developing new drugs averages about $500,000 a day over 12 to 14 years (~$2.5B average cost per new drug). This high development spend has not translated into a meaningful number of additional new medical entities approved by the FDA (about ~35 per year). High development costs and thin pipelines have led many companies to shift towards a strategy of acquiring new drugs by...

Read More
Isolating the Cardholder Data Environment with Network Segmentation

Isolating the Cardholder Data Environment with Network Segmentation

In a recent post, we discussed many of the challenges with attesting to PCI DSS compliance, including a description of some of the factors that are often overlooked when defining the cardholder data environment (CDE). See “Common Misconceptions around the Payment Card Industry Data Security Standard (PCI DSS)” from our recent series of blogs on PCI DSS-related topics for more information. …

Read More

Role of Identity Management – Removing the Friction

With what seems like a daily stream of news related to data breaches these days, why is identity and access management (IAM) still: Not moved to the top of every CIO/CTO roadmap Only talked about as just the management of an identity and not also the governance of that identity Not a standard swim lane with every project that requires any type of authentication to any service (on-premises or...

Read More

Fax? Isn’t that technology extinct?

For years, I have been hearing this from everyone around me. Business and IT organizations saw the predictions that faxing would die (almost instantly when email gained popularity) and most companies did not invest in a dying technology. Why would they? A few years ago, in the early 2000s, I worked for a corporate Fortune 50 IT organization that was not investing in the technology despite the...

Read More

What’s Your Personal Brand? Manage Your Brand for Career Success

 “Today you are You, that is truer than true. There is no one alive who is Youer than You.” – Dr. Seuss This inspirational quote from Dr. Seuss reminds us of the importance of being ourselves. This lesson from childhood applies to personal branding in the workplace today. In this blog post, part 1 of a 2 part series, I share my personal branding experience and explore the need for managing...

Read More
Phone: 312-602-4000
Email: marketing@westmonroepartners.com
222 W. Adams
Chicago, IL 60606
Show Buttons
Share On Facebook
Share On Twitter
Share on LinkedIn
Hide Buttons